Pronociceptive actions of dynorphin via bradykinin receptors.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuroscience Letters

• Publication date

  2008-06-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neulet.2008.03.088PMID 18450375PMCID PMC2767248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spinal dynorphin and bradykinin receptors maintain inflammatory hyperalgesia.

  2008cited by this paper
• Increased spinal dynorphin contributes to chronic nicotine-induced mechanical hypersensitivity in the rat.

  2007cited by this paper
• Dynorphin A activates bradykinin receptors to maintain neuropathic pain

  2006cited by this paper
• Opioid, cheating on its receptors, exacerbates pain

  2006cited by this paper
• Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis.

  2006cited by this paper
• Bradykinin Produces Pain Hypersensitivity by Potentiating Spinal Cord Glutamatergic Synaptic Transmission

  2005cited by this paper
• Pronociceptive role of dynorphins in uninjured animals: N‐ethylmaleimide‐induced nociceptive behavior mediated through inhibition of dynorphin degradation

  2005cited by this paper
• Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance

  2004cited by this paper
• Nonopioid Actions of Intrathecal Dynorphin Evoke Spinal Excitatory Amino Acid and Prostaglandin E2 Release Mediated by Cyclooxygenase-1 and -2

  2004cited by this paper
• Endothelin and the tumorigenic component of bone cancer pain.

  2004cited by this paper
• Dynorphin A (1-17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation.

  2003cited by this paper
• Topical application of dynorphin A (1–17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury

  2002cited by this paper
• Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers

  2002cited by this paper
• Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.

  2002cited by this paper
• Intrathecal Bradykinin Administration: Opposite Effects on Nociceptive Transmission

  2002cited by this paper
• The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.

  2001cited by this paper
• Pronociceptive Actions of Dynorphin Maintain Chronic Neuropathic Pain

  2001cited by this paper
• Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance

  2000cited by this paper
• Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system.

  2000cited by this paper
• Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism.

  2000cited by this paper
• Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve‐injured rats

  2000cited by this paper
• High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors.

  1999cited by this paper
• High-Affinity Interaction of ( des-Tyrosyl ) Dynorphin A ( 2-17 ) with NMDA Receptors 1

  1999cited by this paper
• Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.

  1999cited by this paper
• Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons.

  1998cited by this paper
• Dynorphin mRNA Expression in Dorsal Horn Neurons After Traumatic Spinal Cord Injury: Temporal and Spatial Analysis Using In Situ Hybridization

  1998cited by this paper
• Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations.

  1997cited by this paper
• Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin.

  1996cited by this paper
• Pre-emptive dynorphin and N-methyl-D-aspartate glutamate receptor antagonism alters spinal immunocytochemistry but not allodynia following complete peripheral nerve injury.

  1996cited by this paper
• Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone

  1996cited by this paper
• The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat.

  1995cited by this paper
• Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes.

  1994cited by this paper
• Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.

  1994cited by this paper
• Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model.

  1993cited by this paper
• Autoradiographic localization of [125I‐TYR8]‐bradykinin receptor binding sites in the guinea pig spinal cord

  1993cited by this paper
• Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-Pro.

  1992cited by this paper
• Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism

  1992cited by this paper
• Experimental peripheral neuropathy decreases the dose of substance P required to increase excitatory amino acid release in the CSF of the rat spinal cord.

  1992cited by this paper
• A strychnine-sensitive site is involved in dynorphin-induced paralysis and loss of the tail-flick reflex.

  1991cited by this paper
• Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury

  1990cited by this paper
• Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy.

  1990cited by this paper
• Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects.

  1990cited by this paper
• Induction of the gene encoding pro-dynorphin by experimentally induced arthritis enhances staining for dynorphin in the spinal cord of rats.

  1989cited by this paper
• A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptor.

  1989cited by this paper
• Intrathecal bradykinin acts presynaptically on spinal noradrenergic terminals to produce antinociception in the rat.

  1989cited by this paper
• Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.

  1988cited by this paper
• Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.

  1988cited by this paper
• In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia.

  1988cited by this paper
• Increased staining of immunoreactive dynorphin cell bodies in the deafferented spinal cord of the rat.

  1988cited by this paper
• The degradation of dynorphin A in brain tissue in vivo and in vitro.

  1987cited by this paper
• Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.

  1986cited by this paper
• Sequence and expression of the rat prodynorphin gene.

  1985cited by this paper
• Increased dynorphin immunoreactivity in spinal cord after traumatic injury.

  1985cited by this paper
• Dynorphin‐related peptides cause motor dysfunction in the rat through a non‐opiate action

  1984cited by this paper
• Dynorphin is a specific endogenous ligand of the kappa opioid receptor.

  1982cited by this paper
• Comparison of the distribution of dynorphin systems and enkephalin systems in brain.

  1982cited by this paper
• Opioid peptides have found their roots

  1982cited by this paper
• Dynorphin (1-17): lack of analgesia but evidence for non-opiate electrophysiological and motor effects.

  1982cited by this paper
• Nonopiate effects of dynorphin and des-Tyr-dynorphin.

  1982cited by this paper
• Identification of two related pentapeptides from the brain with potent opiate agonist activity

  1975cited by this paper

• Acute Opioid Administration Undermines Recovery after SCI: Adverse Effects Are Not Restricted to Morphine

  2025cites this paper
• Kinins and their B1 and B2 receptors as potential therapeutic targets for pain relief.

  2022cites this paper
• The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency

  2022cites this paper
• Adverse Effects of Repeated, Intravenous Morphine on Recovery after Spinal Cord Injury in Young, Male Rats Are Blocked by a Kappa Opioid Receptor Antagonist

  2022cites this paper
• Atypical opioid receptors: unconventional biology and therapeutic opportunities.

  2021cites this paper
• The Role of Bradykinin Receptors in the Etiopathogenesis of Chronic Spontaneous Urticaria

  2021cites this paper
• Pain, negative affective states and opioid-based analgesics: Safer pain therapies to dampen addiction.

  2021cites this paper
• Replacement of current opioid drugs focusing on MOR-related strategies.

  2020cites this paper
• Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges

  2020cites this paper
• Inhibitors of neuropeptide peptidases engaged in pain and drug dependence.

  2020cites this paper
• Methanol Extract of Dicranopteris linearis Leaves Attenuate Pain via the Modulation of Opioid/NO-Mediated Pathway

  2020cites this paper
• Endogenous and Exogenous Opioids in Pain.

  2018cites this paper
• Mechanisms Underlying Bone and Joint Pain

  2018cites this paper
• Kininase 1 As a Preclinical Therapeutic Target for Kinin B1 Receptor in Insulin Resistance

  2017cites this paper
• Involvement of the Bradykinin B1 Receptor in Microglial Activation: In Vitro and In Vivo Studies

  2017cites this paper
• Inhibitory effects of dynorphin 3–14 on the lipopolysaccharide‐induced toll‐like receptor 4 signalling pathway

  2017cites this paper
• Structure-Activity Relationships of [des-Arg7]Dynorphin A Analogues at the κ Opioid Receptor.

  2016cites this paper
• Contribution and interaction of kinin receptors and dynorphin A in a model of trigeminal neuropathic pain in mice.

  2015cites this paper
• Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.

  2015cites this paper
• Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord.

  2014cites this paper
• Role of kinin B2 receptors in opioid-induced hyperalgesia in inflammatory pain in mice

  2013cites this paper
• The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction.

  2011cites this paper
• Neurochemistry of Endogenous Antinociception

  2011cites this paper
• Attenuation of Persistent Experimental Pancreatitis Pain by a Bradykinin B2 Receptor Antagonist

  2010cites this paper
• Central modulation of pain.

  2010cites this paper
• The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.

  2009cites this paper
• Spinal Dynorphin and Neuropathic Pain

  2009cites this paper
• Dynorphin Opioid Peptides Enhance Acid-Sensing Ion Channel 1a Activity and Acidosis-Induced Neuronal Death

  2009influential citation
• Analgesic Efficacy of Peripheral &kgr;-Opioid Receptor Agonist CR665 Compared to Oxycodone in a Multi-modal, Multi-tissue Experimental Human Pain Model: Selective Effect on Visceral Pain

  2009cites this paper
• Anticonvulsant Met-enkephalin analogues containing backbone spacers reveal alternative non-opioid signaling in the brain.

  2009cites this paper